Refine by MP, party, committee, province, or result type.

Results 16-23 of 23
Sorted by relevance | Sort by date: newest first / oldest first

Health committee  I think the question you asked about the contact between NACI and the company is a good one. The match between the deliveries and the schedule of vaccination is an important one. I don't think that at this stage Pfizer could be involved at another stage of the discussion. As it

March 8th, 2021Committee meeting

Dr. Nathalie Grandvaux

Health committee  Absolutely, yes. One of the current hypotheses is that some of the variants emerge in immunocompromised people because they don't have the full immunity. It would be the same with the vaccine.

March 8th, 2021Committee meeting

Dr. Nathalie Grandvaux

Health committee  The study in which Dr. De Serres participated is actually a second analysis of clinical data published as part of clinical trials. It's a different way of analyzing the data. They removed the data from the first seven days of the clinical trial on the basis that it's well known

March 8th, 2021Committee meeting

Dr. Nathalie Grandvaux

Health committee  It's certainly a challenge, given that science is being carried out in real time now. Usually, clinical trials for a vaccine take about 10 years. In this case, the whole process was condensed into one year given the urgency of the situation. All the usual developments are visible

March 8th, 2021Committee meeting

Dr. Nathalie Grandvaux

Health committee  Yes, unfortunately.

March 8th, 2021Committee meeting

Dr. Nathalie Grandvaux

Health committee  This adds a level of confusion. I say “unfortunately,” but if I were optimistic enough, I would say that the CIQ and other provincial agencies should be working with the federal agencies. However, I'm not very optimistic about that.

March 8th, 2021Committee meeting

Dr. Nathalie Grandvaux

Health committee  Yes, I have.

March 8th, 2021Committee meeting

Dr. Nathalie Grandvaux

Health committee  Thank you. Good afternoon, Mr. Chair, members of the committee and fellow witnesses. First of all, let me thank you for the opportunity to appear before you today. Just to present myself a little bit, I am a full professor in biochemistry and molecular medicine at Université d

March 8th, 2021Committee meeting

Dr. Nathalie Grandvaux